Wang S J, Hung H M
Division of Biometrics I, CDER/FDA, Rockville, Maryland 20852, USA.
Biometrics. 1997 Sep;53(3):1081-91.
For two-period crossover trials where the residual carryover can only exist in the presence of treatment effect, Willan (1988, Biometrics 44, 211-218) recommended use of the maximum test statistic that chooses the analysis with the larger test statistic corresponding to the parallel analysis and the crossover analysis. We construct two alternative two-stage test procedures, based on Grizzle's approach, that maintain the actual type I error rate at the desirable level. The power, accuracy, and precision of the analysis based on the modified two-stage procedures are compared to those based on the parallel analysis, crossover analysis, and the maximum test statistic.
对于两阶段交叉试验,其中残余遗留效应仅在存在治疗效果时才会出现,威兰(1988年,《生物统计学》44卷,211 - 218页)建议使用最大检验统计量,该统计量选择与平行分析和交叉分析相对应的具有较大检验统计量的分析方法。我们基于格里兹尔的方法构建了两种替代的两阶段检验程序,将实际的I型错误率维持在期望水平。将基于修正后的两阶段程序的分析的功效、准确性和精确性与基于平行分析、交叉分析和最大检验统计量的分析进行比较。